The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.
about
Interventions to improve the appropriate use of polypharmacy for older peopleInterventions to improve the appropriate use of polypharmacy for older peopleHeart failure and socioeconomic status: accumulating evidence of inequalityClinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review.Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study.Medication self-management skills and cognitive impairment in older adults hospitalized for heart failure: A cross-sectional study.Epidemiology of chronic kidney disease in heart failure.Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitusReadmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort studyPatient risk factors for developing a drug-related problem in a cardiology ward.Development and evaluation of a medication counseling workshop for physicians: can we improve on 'take two pills and call me in the morning'?Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans.Trends in comorbidity, disability, and polypharmacy in heart failureGeographic region and racial variations in polypharmacy in the United StatesPolypharmacy in elderly patients at discharge from the acute care hospitalNon-cardiac comorbidities in chronic heart failure.Reverse auction: a potential strategy for reduction of pharmacological therapy cost.Cognitive function and treatment adherence in older adults with heart failure.Patient-reported selective adherence to heart failure self-care recommendations: a prospective cohort study: the Atlanta Cardiomyopathy Consortium.Profile of carvedilol controlled-release: a new once-daily formulation of carvedilol.3D: a tool for medication discharge education.Lipid-lowering therapy and outcomes in heart failure.Protocol-Driven Allied Health Post-Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure.Human Organotypic Cultured Cardiac Slices: New Platform For High Throughput Preclinical Human Trials.Use of guideline-recommended therapies for heart failure in the Medicare population.A drug interactions elective course.Impact of drugs counselling by an undergraduate pharmacist on cardiac surgical patient's compliance to medicines.Role of carvedilol controlled-release in cardiovascular disease.Quality of drug prescribing in older patients: is there a problem and can we improve it?Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure.The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient.Impact of an intervention to reduce medication regimen complexity for older hospital inpatients.Polypharmacy in heart failure patients.Intentional non-adherence to medications by older adults.Association Between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients With Heart Failure.Association between medication regimen complexity and pharmacotherapy adherence: a systematic review.A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure.Patient and Facility Variation in Costs of VA Heart Failure PatientsIn geriatric patients, delirium symptoms are related to the anticholinergic burden.Medication regimen complexity in ambulatory older adults with heart failure.
P2860
Q24193171-C8B36E69-DD8B-4610-9E27-001F295716D7Q24197711-F0D79F3C-14FC-4D79-9546-3CBD8398E18EQ27012972-D064EF8E-DD22-4123-90FD-E70C6A9D723DQ30240010-90568A39-6672-426D-A937-3E1500D46D9DQ30725233-077CBD98-1575-4DDC-B8EE-8C534D4ADF39Q33694022-90D15C04-06ED-4477-9F94-0EC54AD54778Q33978466-DD4D4B14-AB90-4DE3-A643-B0D2AE6414FEQ34024171-5CABCDCC-40D5-4EE3-A7AD-7AABCB9F9E22Q34275502-910353A9-3E85-48ED-938C-944CC3C80DBAQ34764219-BAD0E893-88E9-4237-BF6F-D20503A6742FQ35208597-7A8E4996-A6AE-4258-81C5-B066D25AF66FQ35235532-7C79D99A-7F99-40E1-86E8-1815D354433FQ35611459-32E49D87-B45F-41C4-A16F-40A72F8861A5Q35623075-0AD4E396-37BB-483E-94F2-9D3275D540D5Q35919205-F9FE011F-19FA-4C35-9452-810BD4140087Q35954727-83BEFDEF-E488-406D-A504-9B1A2D80EB00Q36117024-B68A5FC0-DC54-4C70-8617-CCEEC9F1ECD7Q36400283-D12A4AFC-5BCA-4821-BBC3-CB0C27FECCE4Q36460371-16D263BB-DE1A-46C1-B78C-58521DABD398Q36675404-BE55F01C-5E04-4866-9AC0-40EC2F1785FEQ36767287-52D7B60D-39AA-4E90-9169-9992DABB2E0CQ36818242-AE122F76-6897-468E-8205-40BE8A9EF5E8Q36836393-0537370D-7F74-4AAD-8596-52E9FCBEA1C9Q37054318-E71B91F8-E262-41B9-95CE-92F2C57DAA12Q37087394-A18A6A2C-B884-4E97-9DAA-9DB8EBF422CBQ37287907-5DBEA00F-31DB-4DBB-AE15-709BB287F8CCQ37408282-0E93F905-E03E-46C1-BCB6-DB1475D53598Q37472042-FBFE6114-A03C-44F6-A5F5-A975E1220D0DQ37588058-EF2B1460-B30C-4539-8675-27DE3B0A125FQ37786547-EAA28E69-DDC5-4FF0-A74F-00897FE7B11EQ37993441-9D4C5AFE-D92B-4DAF-88B8-CA13EB843DCAQ38065117-951541F8-8983-477A-A1A4-DF8CE6C19597Q38184967-30C1EA39-1AE2-4097-833D-D24841CBD670Q38190869-CF7C9F78-F3B1-46BD-B834-701E6B3F5908Q38384130-FF2CA638-B852-42AD-B20A-0204405D7684Q38639382-53123A1E-E55E-40CD-9DB0-29D9A2C26235Q38682440-C1BB7AAD-470F-4C3D-B842-36FD9335F9CEQ40995976-B087337E-3BFC-4487-BF45-E186DAE2EEEBQ41754885-883E75FD-3114-4E84-9F08-B34CEC1D9EC1Q41808958-FE7E4413-81F6-40D0-A6A0-2A938590D5A8
P2860
The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The complexity and cost of dru ...... the United States, 1998-2001.
@ast
The complexity and cost of dru ...... the United States, 1998-2001.
@en
The complexity and cost of dru ...... the United States, 1998-2001.
@nl
type
label
The complexity and cost of dru ...... the United States, 1998-2001.
@ast
The complexity and cost of dru ...... the United States, 1998-2001.
@en
The complexity and cost of dru ...... the United States, 1998-2001.
@nl
prefLabel
The complexity and cost of dru ...... the United States, 1998-2001.
@ast
The complexity and cost of dru ...... the United States, 1998-2001.
@en
The complexity and cost of dru ...... the United States, 1998-2001.
@nl
P2093
P50
P921
P1476
The complexity and cost of dru ...... the United States, 1998-2001.
@en
P2093
Edward P Havranek
JoAnne Micale Foody
John F Steiner
W David Bradford
Yongfei Wang
P304
P356
10.1001/ARCHINTE.165.18.2069
P407
P577
2005-10-01T00:00:00Z